Toggle Main Menu Toggle Search

Open Access padlockePrints

Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment.

Lookup NU author(s): Dr Santu SahaORCiD, Rachel Howarth, Dr Isabel Pappworth, Professor Kevin MarchbankORCiD, Professor Nicola CurtinORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Saha S, Howarth R, Pappworth I, Marchbank K, Curtin N

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Year of Conference: 2020

Pages: S37-S37

Online publication date: 26/10/2020

Acceptance date: 26/10/2020

ISSN: 0959-8049

Publisher: Elsevier Ltd


DOI: 10.1016/S0959-8049(20)31169-2

Series Title: European Journal of Cancer